SCHEMBL22878265

SCHEMBL22878265

C=C1CC(O)C2C(=C)C(O)OC2C2C(=C)C(=O)CC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10307518 0.78 MAPT (0.32) —
SCHEMBL12459727 0.70 MAPK1 (0.41) —
SCHEMBL15449258 0.67 MEN1 (0.31) —
Desacylcynaropicrin SCHEMBL10307509 0.61 MAPT (0.33) —
SCHEMBL19751054 0.61 TXNRD1 (0.32) —
SCHEMBL18180889 0.56 MAPT (0.35) —
SCHEMBL10307520 0.56 MAPT (0.35) —
Grossheimin SCHEMBL1711489 0.56 MAPT (0.34) —
Grossheimin SCHEMBL1711493 0.56 MAPT (0.34) —
SCHEMBL22422625 0.56 PTGS2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3763419-A1 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES Anji Pharma (US) LLC (US) 2021-01-13 — — EP disclosed
Send feedback